Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 2019 and is based in Ness Ziona, Israel.

Sector

Healthcare

Industry

Biotechnology

CEO

Hakim, Gil

Employees

Website

matricelf.com

IPO Date

2021-06-21

Headquarters

Golda Meir 3, Ness Ziona 7651713, Israel

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Matricelf MTLF

Matricelf Earnings Call Summary

Matricelf Earnings

Transcripts

Events

About Matricelf Ltd

Matricelf
MTLF